Sree Rayalaseema Hi-Strength Hypo (SRHHYPOLTD) Fundamentals 2026 — P/E 9.3x, Revenue Analysis | SniperIQ
Sree Rayalaseema Hi-Strength Hypo (SRHHYPOLTD) is a India-listed Basic Materials company in Chemicals with a market capitalization of ₹832 Crore, trading at ₹484.60 on the NSE. This SniperIQ fundamentals page covers Sree Rayalaseema Hi-Strength Hypo's valuation (P/E 9.3x, P/B 0.8x), profitability (net margin 13.4%), revenue (₹667 Crore in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Sree Rayalaseema Hi-Strength Hypo's market cap?
Sree Rayalaseema Hi-Strength Hypo (SRHHYPOLTD) has a market capitalization of approximately ₹832 Crore, trading at ₹484.60 on the NSE. Market cap moves with the live share price.
What is Sree Rayalaseema Hi-Strength Hypo's P/E ratio?
Sree Rayalaseema Hi-Strength Hypo's trailing twelve-month P/E ratio is 9.3x, with a price-to-book (P/B) of 0.8x. Valuation multiples are best compared with Basic Materials sector peers rather than read in isolation.
How profitable is Sree Rayalaseema Hi-Strength Hypo?
Sree Rayalaseema Hi-Strength Hypo runs a net profit margin of 13.4%, a gross margin of 43.7%, and an operating margin of 12.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Sree Rayalaseema Hi-Strength Hypo generate?
Sree Rayalaseema Hi-Strength Hypo reported revenue of ₹667 Crore for fiscal year 2026, with net income of ₹90 Crore and earnings per share (EPS) of 53.25. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Sree Rayalaseema Hi-Strength Hypo pay a dividend?
Sree Rayalaseema Hi-Strength Hypo offers a trailing dividend yield of about 0.6%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Sree Rayalaseema Hi-Strength Hypo financially healthy?
Sree Rayalaseema Hi-Strength Hypo carries a debt-to-equity ratio of 0.01x and a current ratio of 10.51x, with a market beta of 0.45. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Sree Rayalaseema Hi-Strength Hypo a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Sree Rayalaseema Hi-Strength Hypo (SRHHYPOLTD) the key facts are: market cap ₹832 Crore, P/E 9.3x, revenue ₹667 Crore, 52-week range 382.4-676.45. Weigh valuation, profitability, growth, and balance-sheet strength against Basic Materials peers and form your own view.
Track Sree Rayalaseema Hi-Strength Hypo's full fundamentals live
Get Sree Rayalaseema Hi-Strength Hypo's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.